Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Private Equity-Backed Covis Bids To Buy Troubled AMAG

Oct 02 2020

• By Joseph Haas

DealWatch_1200x675

Related Content

Neuraxpharm Snapped Up By Private Equity In Europe’s Largest Deal

Sep 22 2020

Inflexion Outlines Rosemont Investment And Eyes More Generics Deals

Sep 24 2020

Alvotech And DKSH Extend Partnership For Six Biosimilars

Sep 25 2020

AMAG Open To Another Makena Trial, But Also Appears Ready To Challenge Any Withdrawal Request

Nov 06 2019

Genfit Not Fully Exiting NASH, Despite Terminating RESOLVE-IT

Jul 23 2020

Roche Takes SCENIC Route On Genetic Modifiers

Sep 23 2020

Pfizer Bets $480m On CStone And Surging China Immuno-Oncology Market

Sep 30 2020

Stada Progresses In Parkinson's With Lobsor Purchase

Oct 02 2020

Ligand Set For Partnership Opportunities After Completing On Pfenex

Oct 02 2020

Related Companies

Covis Pharma B.V.

AMAG Pharmaceuticals Inc.

Millicent Pharma Limited

Palatin Technologies, Inc.

Norgine B.V.

Vincerx Pharma, Inc.

Bayer AG

Genfit SA

Bial Pharmaceuticals

Lysosomal Therapeutics Inc.

Neuropore Therapies, Inc.

Antares Pharma, Inc.

Ferring Pharmaceuticals

Genuity Science

Ionis Pharmaceuticals, Inc.

Laboratory Corporation of America

Orgenesis, Inc.

Vor Biopharma Inc.

Arbor Biotechnologies

AbCellera Biologics Inc.

IGM Biosciences, Inc.

Relief Therapeutics Holding AG

Cend Therapeutics, Inc.

Impilo Therapeutics, Inc.

Recordati SpA

ARS Pharmaceuticals, Inc.

Additional Topics

Deals Business Strategies M & A Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window